Loss of fragile histidine triad protein in human hepatocellular carcinoma (Q36179787)

12 August 2017

Loss of fragile histidine triad protein in human hepatocellular carcinoma (English)

1 reference

12 August 2017

hepatocellular carcinoma

1 reference

Po Zhao

1

1 reference

12 August 2017

Xin Song

2

1 reference

12 August 2017

Yuan-Yuan Nin

3

1 reference

12 August 2017

Ya-Li Lu

4

1 reference

12 August 2017

Xiang-Hong Li

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

World Journal of Gastroenterology

12 August 2017

1 reference

12 August 2017

9

1 reference

12 August 2017

6

1 reference

12 August 2017

1216-1219

1 reference

Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

The role of deletions at the FRA3B/FHIT locus in carcinogenesis.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Absence or reduction of Fhit expression in most clear cell renal carcinomas.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Aberrant FHIT transcripts in hepatocellular carcinomas

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

FHIT gene alterations in head and neck squamous cell carcinomas

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Abnormal Fhit expression in malignant and premalignant lesions of the cervix.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Loss of FHIT expression in gastric carcinoma.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4611787

The FHIT gene at 3p14.2 is abnormal in breast carcinomas

21 October 2018

1 reference

12 December 2020

Loss of FHIT function in lung cancer and preinvasive bronchial lesions

1 reference

12 December 2020

The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers

1 reference

12 December 2020

Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas

1 reference

12 December 2020

Role of FHIT in human cancer

1 reference

12 December 2020

Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions

1 reference

12 December 2020

Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines

1 reference

12 December 2020

Evaluation of the FHIT gene in colorectal cancers

1 reference

12 December 2020

Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix

1 reference

12 December 2020

FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease

1 reference

12 December 2020

Alterations of the FHIT gene in human hepatocellular carcinoma.

1 reference

12 December 2020

Study of FHIT transcripts in normal and malignant breast tissue

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V9.I6.1216

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

12800227

1 reference